Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.9M
-
Number of holders
-
176
-
Total shares
-
53.4M
-
Shares change
-
-350K
-
Total reported value, excl. options
-
$2.21B
-
Value change
-
-$15M
-
Number of buys
-
82
-
Number of sells
-
-82
-
Price
-
$41.36
Significant Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q2 2015
176 filings reported holding HAE - HAEMONETICS CORP - Common Stock as of Q2 2015.
HAEMONETICS CORP - Common Stock (HAE) has 176 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.4M shares
.
Largest 10 shareholders include Neuberger Berman Group LLC (4.15M shares), VANGUARD GROUP INC (3.76M shares), BlackRock Fund Advisors (3.02M shares), WELLS FARGO & COMPANY/MN (2.35M shares), BARROW HANLEY MEWHINNEY & STRAUSS LLC (2.34M shares), FMR LLC (2.28M shares), WESTWOOD HOLDINGS GROUP INC (2.08M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.8M shares), WELLINGTON MANAGEMENT GROUP LLP (1.73M shares), and Black Creek Investment Management Inc. (1.65M shares).
This table shows the top 176 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.